Business Context and Reporting Period
Company: iBio, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 2, 2023
Reporting Period: Single event date (October 2, 2023)
Business Context: The filing serves as a Regulation FD disclosure to update the market with a revised corporate presentation.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of an updated investor presentation rather than a financial statement.
Material Changes
Item 7.01 (Regulation FD Disclosure): The Company has updated its corporate presentation. A copy of this presentation is furnished as Exhibit 99.1. No other material changes to operations or financial status are detailed in the text of this specific filing.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The attached corporate presentation (Exhibit 99.1) contains "forward-looking" statements subject to "safe harbor" language under the Private Securities Litigation Reform Act of 1995.
- Update Obligation: The Company explicitly states it undertakes no duty or obligation to update or revise the information contained in this report or the attached presentation, though it may do so at management's discretion.
- Legal Status: The information in Item 7.01 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other SEC filings.
Investor Verification Checklist
- Review Exhibit 99.1 (iBio, Inc. Investor Presentation, dated October 2023) for the specific updated data and forward-looking guidance referenced in this filing.
- Verify the trading symbol IBIO on the NYSE American exchange.
- Note that the Company has disclaimed any obligation to update the forward-looking statements contained in the attached presentation.